A population-based cohort study in Qatar showed reinfections had 90% lower odds of resulting in hospitalization or death than primary infections.
Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections – New England Journal of Medicine Related: [Preprint] M-A of 12.011.447 individuals finds individuals previously infected with SARS-CoV-2 had an 81% reduction in odds of a reinfection.
The post A population-based cohort study in Qatar showed reinfections had 90% lower odds of resulting in hospitalization or death than primary infections. appeared first on Links Medicus.
Review: Noninvasive ventilation and oxygenation strategies.
Noninvasive Ventilation and Oxygenation Strategies – Surgical Clinics of North America
The post Review: Noninvasive ventilation and oxygenation strategies. appeared first on Links Medicus.
Basics of extracorporeal membrane oxygenation.
Basics of Extracorporeal Membrane Oxygenation – Surgical Clinics of North America
The post Basics of extracorporeal membrane oxygenation. appeared first on Links Medicus.
A prospective cohort study showed a 3.1% risk for recurrent venous thromboembolism at 90 days in patients with subsegmental pulmonary embolism managed without anticoagulation.
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation: A Multicenter Prospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text) Commentary on Twitter First prospective study including patients with isolated SSPE managed without anticoagulation published in @AnnalsofIM. Rate of recurrent VTE is 3.1% […]
The post A prospective cohort study showed a 3.1% risk for recurrent venous thromboembolism at 90 days in patients with subsegmental pulmonary embolism managed without anticoagulation. appeared first on Links Medicus.
We expected people with asthma to fare worse during COVID. Turns out they’ve had a break.
We expected people with asthma to fare worse during COVID. Turns out they’ve had a break – The Conversation
The post We expected people with asthma to fare worse during COVID. Turns out they’ve had a break. appeared first on Links Medicus.
Review: COVID-19-associated Invasive Fungal Infection.
COVID-19-associated Invasive Fungal Infection – Open Forum Infectious Diseases Related: Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. M-A: Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis – The incidence and mortality in the ICU were estimated to be 10.2% and 54.9%, respectively. Consensus Guideline: Defining and managing COVID-19-associated pulmonary aspergillosis […]
The post Review: COVID-19-associated Invasive Fungal Infection. appeared first on Links Medicus.
Populational study in France did not show an increased incidence of acute myocardial infarction, stroke, and pulmonary embolism following the Pfizer vaccine.
Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older – JAMA
The post Populational study in France did not show an increased incidence of acute myocardial infarction, stroke, and pulmonary embolism following the Pfizer vaccine. appeared first on Links Medicus.
M-A: Colchicine doesn’t lessen COVID-19 severity or stave off risk of death.
News release: Gout drug colchicine doesn’t lessen COVID-19 severity or stave off risk of death – BMJ Original Study: Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials – RMD Open Related: RECOVERY Trial: In patients admitted to hospital with COVID-19, Colchicine did not reduce 28-day mortality, duration of hospital stay, […]
The post M-A: Colchicine doesn’t lessen COVID-19 severity or stave off risk of death. appeared first on Links Medicus.
[Preprint] Systematic Review: Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease – “effectiveness against COVID-19 severe disease remained high (>70%) in most studies in the six months after full vaccination, although
Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease: Results of a Systematic Review and Meta-Regression – Preprints with The Lancet – SSRN Related: Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. China’s COVID vaccines have been crucial — now immunity is waning. [Preprint] Breakthrough SARS-CoV-2 infections in 620,000 U.S. Veterans, February 1, 2021 to […]
The post [Preprint] Systematic Review: Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease – “effectiveness against COVID-19 severe disease remained high (>70%) in most studies in the six months after full vaccination, although it did decrease some (on average, 8-10 percentage points) between one and six months after full vaccination”. appeared first on Links Medicus.
Is Delta the last Covid ‘super variant’?
Is Delta the last Covid ‘super variant’? – The Guardian
The post Is Delta the last Covid ‘super variant’? appeared first on Links Medicus.